
Real Estate Professional representing Central Ohio. Husband to the wonderful @Ashley_Rosko1 Father to my four boy's Eli, Jack, Ruffles and Feathers.
Joined April 2020
- Tweets3.1K
- Following388
- Followers175
- Likes3.6K
Pinned Tweet
Still riding the wave of excitement from winning the @Pelotonia scrubs from @OSUHematology #ThrowbackThursdays contest I'm throwing my hat back in the ring!! Please consider supporting my ride for cancer research!
pelotonia.org/profile/JR7258…
Rosko Realtor retweeted
The Ohio State vs. Michigan Blood Battle kicked off this week, running through November 25. Let’s bleed scarlet and bring that trophy home for the FIFTH year in a row!
By giving, you will directly impact the lives of patients at @osuwexmed.🩸versiti.org/get-involved/fea…
Rosko Realtor retweeted
🌰We're hiring! Click the link below to learn more ⬇️
@OSUCCC_James
go.osu.edu/joindomoatosu
Rosko Realtor retweeted
👏 Celebrating @AkEisfeld for representing @OSUCCC_James at this important plenary on genetic ancestry, admixture, and cancer disparities! We’re proud to see our faculty leading conversations that advance cancer research and health equity. 🎉educational events!
Session chairs Christopher Flowers and Luis G. Carvajal-Carmona joined Leslie Cuellar-Vite, Sanket Shah, and Ann-Kathrin Eisfeld in a plenary on "Genetic Ancestry, Admixture, and Cancer Disparities" at #AACRdisp26. @drsanket2086 @AkEisfeld
🩸 HemeHub is honored to have Spero Cataland, MD, as part of our Scientific Advisory Board.
Dr. Cataland is a hematologist, Professor in the Division of Hematology, and Director of Classical Hematology at The Ohio State University (@OSUCCC_James). His clinical expertise includes platelet disorders, bleeding and clotting disorders, hemophilia, and von Willebrand disease.
Dr. Cataland's research focuses on rare blood disorders, including TTP and aHUS. His work also includes international clinical trials and publications in prominent medical journals, including The New England Journal of Medicine, Blood, and the Journal of Thrombosis and Haemostasis.
We are proud to have his expertise and leadership helping shape HemeHub’s commitment to advancing hematology education.
🌐 Learn more: hemehub.org
#HemeHub #Hematology #BloodDisorders #ClassicalHematology #MedicalEducation #ClinicalResearch
🩸Introducing the HemeHub Scientific Advisory Board!
We are proud to be supported by an exceptional group of internationally recognized leaders in hematology.
Through their independent scientific guidance and commitment to evidence-based medicine, they help ensure HemeHub continues to provide high-quality, unbiased education that supports clinicians and improves patient care.
🌟Explore more: hemehub.org
#HemeHub #Hematology #MedicalEducation #ScientificAdvisoryBoard #ClinicalHematology #HemeOnc #MedEd @NIH @UTSWMedCenter @utswcancer @UTSWHemeOnc @KeckMedicineUSC @uvamedicine @UVACancerCenter @MedicineUVA @uvahealthnews @PennMedicine @OSUWexMed @UChicagoMed
Rosko Realtor retweeted
Drs. Anghelina, Bhat, Blachly, Grever, Oakes, and Rogers attended the @HCLFoundation Annual Scientific Meeting and Patient Meeting in New York City last week. Drs. Anghelina, Bhat, Grever, Rogers & Oakes presented at the Patient Meeting, sharing their expertise and insights.
Rosko Realtor retweeted
Christian Rolfo, MD, PhD, MBA,Dr.hc on 8 Liquid Biopsy Applications to Accelerate Drug Development - Roberto Borea
@RobertoBoreaMD @ChristianRolfo @RolfoLab @OhioStateMedOnc
oncodaily.com/voices/roberto…
Rosko Realtor retweeted
Very honored to be invited in the session “challenge your expert” at #ESMO26 on a very interesting topic “use of liquid biopsy in early drug development “ with the great moderation of @ClaraMontagut
@OSUCCC_James
@OhioStateMedOnc
@myESMO
@isliquidbiopsy
@rolfolab
Replying to @ChristianRolfo
@ChristianRolfo (@RolfoLab) from @OhioStateMedOnc at #ESMO26 on how #liquidbiopsy can make early phase drug development faster, better and more efficient
8 applications, from patient selection to early signals activity and resistance.
@isliquidbiopsy @myESMO
Rosko Realtor retweeted
Congratulations to @SDevarakondaOSU, on his acceptance into the Dean’s Academy of Educators! 🎉 This honor recognizes his commitment to excellence in medical education and faculty development.
@OhioStateMed
Rosko Realtor retweeted
Congrats to Sarah Wall, MD; Srinivas Devarakonda, MD; Robbi Azbell, MD; Yazeed Sawalha, MD; and Greg Behbehani, MD, PhD, on being named @OSUCCC_James James Service Line Physician Champions! 🎉 Thank you for your outstanding patient care, leadership, innovation, and teamwork. 👏
Rosko Realtor retweeted
Fuat Bicer is Thankful for the 50 Years of Scientific Excellence Celebration by OSUCCC
@fuatbcr @OSUCCC_James
oncodaily.com/positive/fuat-…
Rosko Realtor retweeted
Very proud of @rolfolab team! Presenting 6 outstanding posters at our @OSUCCC_James Annual Scientific Meeting! testament to the talent, dedication, and collaborative spirit of our team.
@OhioStateMedOnc
@GianniNigita @RobertoBoreaMD @fra_drake @IshwarSan22
@KimrynRathmell
Rosko Realtor retweeted
Player. Coach. Legend.
Mike Ditka embodied the spirit of Chicago and will be deeply missed.
WAY TO GO ASHLEY! #womeninmedicine
Congratulations to @Ashley_Rosko1 on her publication in @JGeriOnc! 🎉
Her study examines CARE-pall, an integrative geriatric and palliative care clinic designed to support older adults with complex care needs.
🔗👉doi.org/10.1016/j.jgo.2026.1…
Rosko Realtor retweeted
Congratulations, Dr. Carbone!
Congrats to Dr. David Carbone, a world-renowned thoracic oncologist + physician-scientist, on being named Physician-Scientist of the Year @OSUCCC_James A pleasure to work alongside David to advance team science in lung cancer immuno-oncology. @OhioStatePIIO @KimrynRathmell
Rosko Realtor retweeted
In honor of #WomenInMedicineMonth, we’re proud to spotlight Dr. Liza Cholin, transplant nephrologist @OSUWexMed, for her dedication to patient care, learning & solving complex transplant challenges.
Her advice to women: pursue medicine if it’s what you love. 💙
#NephTwitter
Rosko Realtor retweeted
👏Congrats to @HasanovLab on receiving a @GatewayforCR award for a multicenter phase 2 study of zanzalintinib & combination therapies in untreated or progressive brain metastases in renal cell carcinoma
































